Methylhexanamine is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s. From Wikipedia
The retroactive ban follows a December 2024 sample that detected the stimulant methylhexanamin.
